1. Hospital red blood cell and platelet supply and utilization from March to December of the first year of the COVID‐19 pandemic: The BEST collaborative study
- Author
-
Lu, Wen, Yazer, Mark, Li, Na, Ziman, Alyssa, Wendel, Silvano, Tang, Hongying, Tsang, Hamilton, Titlestad, Kjell, Thibodeaux, Suzanne R, Shih, Andrew W, Poisson, Jessica L, Pham, Tho, Pandey, Suchi, Pagano, Monica B, Shan, Hua, Murphy, Mike, Murphy, Colin, Savioli, Mariana Lorenzi, Kutner, José Mauro, Hess, Aaron S, Fontaine, Magali J, Fachini, Roberta, Dunbar, Nancy M, Kaufman, Richard M, and Collaborative, Biomedical Excellence for Safer Transfusions
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Clinical Research ,Good Health and Well Being ,COVID-19 ,Erythrocyte Transfusion ,Erythrocytes ,Hospitals ,Humans ,Pandemics ,United States ,blood inventory ,days on hand ,demand ,outdate ,par ,SARS-CoV-2 ,supply ,use ,Biomedical Excellence for Safer Transfusions Collaborative ,Cardiorespiratory Medicine and Haematology ,Immunology ,Cardiovascular System & Hematology ,Cardiovascular medicine and haematology ,Clinical sciences - Abstract
BackgroundAt the start of the coronavirus disease 2019 (COVID-19) pandemic, widespread blood shortages were anticipated. We sought to determine how hospital blood supply and blood utilization were affected by the first wave of COVID-19.Study design and methodsWeekly red blood cell (RBC) and platelet (PLT) inventory, transfusion, and outdate data were collected from 13 institutions in the United States, Brazil, Canada, and Denmark from March 1st to December 31st of 2020 and 2019. Data from the sites were aligned based on each site's local first peak of COVID-19 cases, and data from 2020 (pandemic year) were compared with data from the corresponding period in 2019 (pre-pandemic baseline).ResultsRBC inventories were 3% lower in 2020 than in 2019 (680 vs. 704, p
- Published
- 2022